- Home
- LPG vs AMLX Comparison
LPG vs AMLX Comparison
Compare LPG & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPG
- AMLX
- Stock Information
- Founded
- LPG 2013
- AMLX 2014
- Country
- LPG United States
- AMLX United States
- Employees
- LPG N/A
- AMLX N/A
- Industry
- LPG Marine Transportation
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- LPG Consumer Discretionary
- AMLX Health Care
- Exchange
- LPG Nasdaq
- AMLX Nasdaq
- Market Cap
- LPG 1.2B
- AMLX 1.3B
- IPO Year
- LPG 2014
- AMLX 2022
- Fundamental
- Price
- LPG $24.73
- AMLX $14.97
- Analyst Decision
- LPG Strong Buy
- AMLX Strong Buy
- Analyst Count
- LPG 1
- AMLX 7
- Target Price
- LPG $35.00
- AMLX $17.43
- AVG Volume (30 Days)
- LPG 522.8K
- AMLX 1.5M
- Earning Date
- LPG 11-06-2025
- AMLX 11-06-2025
- Dividend Yield
- LPG 13.02%
- AMLX N/A
- EPS Growth
- LPG N/A
- AMLX N/A
- EPS
- LPG 2.23
- AMLX N/A
- Revenue
- LPG $359,008,462.00
- AMLX N/A
- Revenue This Year
- LPG $17.26
- AMLX N/A
- Revenue Next Year
- LPG N/A
- AMLX N/A
- P/E Ratio
- LPG $11.04
- AMLX N/A
- Revenue Growth
- LPG N/A
- AMLX N/A
- 52 Week Low
- LPG $16.66
- AMLX $2.60
- 52 Week High
- LPG $32.79
- AMLX $16.96
- Technical
- Relative Strength Index (RSI)
- LPG 34.06
- AMLX 61.79
- Support Level
- LPG $24.06
- AMLX $14.48
- Resistance Level
- LPG $29.73
- AMLX $15.39
- Average True Range (ATR)
- LPG 0.82
- AMLX 0.95
- MACD
- LPG -0.19
- AMLX 0.21
- Stochastic Oscillator
- LPG 17.87
- AMLX 88.34
About LPG Dorian LPG Ltd.
Dorian LPG Ltd is an international liquefied petroleum gas shipping company focused on owning and operating gas carriers, or VLGCs. The company currently owns and operates around 22 modern VLGCs, including nineteen new fuel-efficient 84,000 cbm ECO-design VLGCs. Dorian LPG has offices in Connecticut, USA, London, United Kingdom, and Athens, Greece. IT operates in one reportable segment, the international transportation of LPG.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.